U.S. Luxury Stock News

Intellia Therapeutics recently saw the US FDA lift a clinical hold on its MAGNITUDE-2 study, allowing an expanded enrollment of around 60 patients under a revised protocol emphasizing additional safety monitoring and data clarity. This resolution, combined with supportive analyst commentary pointing to the rarity of serious liver events, reinforces confidence in Intellia’s in vivo gene-editing platform and broader development partnerships. We’ll now explore how the lifted MAGNITUDE-2...

Herc Holdings, NYSE:HRI, is signaling a more cautious outlook as management plans slower fleet expansion and tighter capital spending. Recent disclosures point to higher operating costs even as revenue continues to grow. The shift comes as investors focus more on profitability and the cyclical nature of the equipment rental sector. Herc Holdings, trading at $173.12, is recalibrating its growth playbook at a time when the stock shows a mixed return profile. Shares are up 13.6% year to date...

Earlier this month, AT&T, Amazon Web Services and Amazon Leo announced a collaboration to modernize U.S. connectivity by combining AT&T’s fiber network, AWS cloud and Amazon’s low Earth orbit satellite services to enhance resilience and expand fixed broadband for business customers. By shifting internal workloads onto AWS Outposts and linking AWS data centers with high-capacity AT&T fiber, the partnership ties AT&T’s network evolution directly to enterprise cloud and AI adoption...

American Eagle Outfitters (AEO) is back in focus after investors reacted to expectations for its upcoming March 4, 2026 earnings release, with attention on projected 31.48% year-over-year earnings growth and positive analyst sentiment. See our latest analysis for American Eagle Outfitters. At a share price of US$25.48, American Eagle Outfitters has seen a 3.83% 1 day share price return and a 7.24% 7 day share price return. The 44.28% 90 day share price return sits alongside a 1 year total...

If you are wondering whether Wingstop shares still offer value after their recent swings, this article will walk through what the current price might be implying and how that stacks up against several valuation yardsticks. The stock closed at US$221.65, with returns of a 16% decline over 7 days, a 19.8% decline over 30 days, a 13.7% decline year to date, a 26.9% decline over 1 year, a 29.2% gain over 3 years and a 66.9% gain over 5 years, which may have shifted how investors see both its...

Albemarle (ALB) just paired stronger quarterly sales with a decision that surprised some lithium investors, putting its last active Kemerton processing train in Australia into care and maintenance in order to focus on profitability and cash flow. See our latest analysis for Albemarle. The Kemerton decision landed alongside a busy few days for Albemarle, with Q4 2025 results, fresh 2026 guidance and updates on asset sales all feeding into the share price reaction. The share price has a 1 day...

BridgeBio Pharma (NasdaqGS:BBIO) reported positive Phase 3 topline results for infigratinib in children with achondroplasia. The PROPEL 3 trial met primary and key secondary endpoints, including improvements in height velocity and body proportionality. Infigratinib is the first therapy in a randomized trial to show statistical significance in improving body proportionality in this patient group. BridgeBio plans to pursue regulatory submissions in the U.S. and Europe in the second half of...

Jones Lang LaSalle (JLL) has come into focus after its share price fell roughly 12% amid weakening sentiment toward real estate stocks following Zillow’s softer profit outlook. This has put extra attention on JLL’s upcoming earnings update. See our latest analysis for Jones Lang LaSalle. The recent 12% pullback sits within a choppy stretch for JLL, with a 7 day share price return of 15.64% decline and a 30 day share price return of 18.69% decline. At the same time, its 1 year total...

In early February 2026, U.S. Bancorp issued and completed multiple callable senior unsecured and unsubordinated fixed-rate notes maturing between 2031 and 2046, including individual tranches such as US$12.67 million of 5.05% notes due 2037 and US$10.56 million of 5.60% notes due 2046, alongside bringing in Raj Gazula as Chief Administrative Officer for its PMI unit. These frequent long-dated bond offerings, combined with concentrated insider share sales and new leadership in payments and...

Dutch Bros (BROS) just wrapped up FY 2025 with fourth quarter revenue of US$443.6 million and basic EPS of US$0.17, capping a twelve month run that produced total revenue of about US$1.6 billion and EPS of roughly US$0.64. Over the past six quarters, the company has seen quarterly revenue move from US$338.2 million to US$443.6 million while basic EPS shifted from US$0.11 in Q3 2024 to a range of US$0.13 to US$0.20 across 2025. This sets up a story where higher net income and a trailing net...

Rexford Industrial Realty (REXR) has drawn fresh attention after reporting full year 2025 results that paired higher sales and revenue with lower net income, along with new 2026 guidance, a dividend increase, and a sizable share repurchase program. See our latest analysis for Rexford Industrial Realty. At a share price of $37.20, Rexford Industrial Realty has seen a 1-day share price return of 0.84%. The 30-day share price return of 9.27% decline and 1-year total shareholder return of 3.62%...

Marathon Petroleum Corporation reported past fourth-quarter 2025 results with sales of US$32,574 million, revenue of US$33,422 million, and net income of US$1,535 million, alongside basic earnings per share from continuing operations of US$5.13. Despite slightly lower sales than a year earlier, the company’s net income and earnings per share rose sharply while it continued large-scale share repurchases, completing about US$45.70 billion of buybacks since 2017. With refining margins rising...

Board changes and activist agreement shift Southwest Gas Holdings (SWX) is back in focus after the company and the Icahn Group ended their cooperation agreement, while Icahn-backed directors remain on the board and are expected to be renominated. See our latest analysis for Southwest Gas Holdings. The end of the cooperation agreement with the Icahn Group comes after a period where momentum has been building. A 10.49% 3 month share price return from a latest share price of US$87.98 and a 1...

Yum! Brands recently reported fourth-quarter and full-year 2025 results, with higher sales, revenue and net income year-on-year, and approved a US$0.75 quarterly dividend per share, while board member Keith Barr resigned on February 10, 2026 to take an external leadership role. Management highlighted that nearly 60% of systemwide sales now come through digital channels, underscoring how technology is reshaping customer ordering and operations across KFC, Taco Bell and Pizza Hut. We’ll now...

Lincoln National (NYSE:LNC) reported its sixth consecutive quarter of adjusted operating earnings growth. The company recorded strong annuity and life insurance sales, reinforcing its core business lines. Lincoln National appointed a new Chief AI, Data & Analytics Officer as it focuses on business diversification and operational improvements. For you as an investor, Lincoln National sits at the intersection of insurance, retirement, and asset protection, areas that remain central to long...

IonQ (IONQ) is back in the spotlight after Norway’s sovereign wealth fund committed US$200 million, along with moves to acquire Skyloom Global and U.S. foundry SkyWater Technology, as investors reassess this vertically focused quantum computing bet. See our latest analysis for IonQ. IonQ’s latest institutional backing and acquisition push lands after a volatile stretch, with an 8.98% 1 day share price gain contrasting with a 32.85% 30 day share price decline and a very large 3 year total...

Neurocrine Biosciences (NBIX) just released its fourth quarter and full-year 2025 results, reporting revenue of US$805.5 million for the quarter and US$2.86 billion for the year, alongside higher net income compared with 2024. See our latest analysis for Neurocrine Biosciences. Despite strong 2025 results and fresh guidance for INGREZZA, the share price has pulled back recently, with a 7 day share price return of a 12.1% decline and a 90 day share price return of a 13.5% decline, while the 1...

In February 2026, Blue Bird Corporation reported first-quarter 2026 results showing sales of US$333.08 million and net income of US$30.76 million, both higher than the prior year, and reaffirmed its full-year 2026 net revenue outlook of US$1.50 billion. The combination of growing quarterly earnings per share and management’s confidence in its full-year revenue guidance provides investors with clearer visibility into Blue Bird’s near-term financial trajectory. Next, we’ll examine how Blue...

Applied Materials (AMAT) is back in focus after fiscal Q1 earnings and revenue came in ahead of expectations, paired with Q2 guidance above consensus and management indicating over 20% growth for its semiconductor equipment business in 2026. See our latest analysis for Applied Materials. The earnings beat, export probe settlement and new AI focused product announcements have coincided with a sharp move in the shares, with a 1 day share price return of 8.1% and a 90 day share price return of...

DexCom, Inc. has reported past fourth-quarter 2025 results with revenue of US$1,259.6 million and net income of US$267.3 million, alongside full-year 2025 sales of US$4.66 billion and net income of US$836.3 million, all ahead of the prior year. The company coupled this earnings beat with improved operating margins, a reiterated 2026 revenue outlook of US$5.16–US$5.25 billion, and progress on AI-enhanced products like Stelo and the G7 15-day CGM system, reinforcing its focus on both...

Pathward Financial (CASH) drew fresh investor attention after an analyst upgrade that was linked to strong Q1 results, resilient fee and commercial finance activity, raised multi-year earnings guidance, and active share repurchases alongside ongoing dividends. See our latest analysis for Pathward Financial. The analyst upgrade came as the share price gained clear momentum, with a 1 day share price return of 4.69% and a 30 day share price return of 22.87%. The 3 year total shareholder return...

If you are wondering whether Shopify's current share price still makes sense for you, it helps to step back and look at what the numbers are actually saying about value. The stock last closed at US$112.70, with recent returns showing a 0.6% gain over 7 days, a 27.7% decline over 30 days, a 28.3% decline year to date, a 12.2% decline over 1 year, and a 158.4% gain over 3 years. Recent attention on Shopify has focused on its role as a key ecommerce platform for merchants and its ongoing...

International Flavors & Fragrances (NYSE:IFF) has started a formal sale process for its Food Ingredients business. The move is part of a broader effort to reshape the portfolio through multiple divestitures and focus on higher value segments. Management is targeting improved capital allocation and an emphasis on businesses it sees as core to long term value creation. IFF enters this phase of portfolio reshaping with its shares at $83.0 and a mixed return profile. The stock is up 10.9% over...

Why PPL (PPL) is on investors’ radar today PPL (PPL) has drawn fresh attention after recent share price moves, with the stock closing at $37.82 and posting positive returns over the past week, month, past 3 months, and year. For investors watching utilities, those steady gains, alongside reported annual revenue of $8.979b and net income of $1.09b, raise questions about how PPL’s current valuation lines up with its recent performance. See our latest analysis for PPL. The recent 1-day share...